The FDA issued an emergency use authorization for the Flowflex rapid home Covid test which should “double home testing capacity in the US over the next several weeks”:
FDA authorizes new home #covid19 rapid antigen test that it says will double home testing capacity in the US over the next several weeks pic.twitter.com/ctC606cgpv
— Meg Tirrell (@megtirrell) October 4, 2021
Why the rush, FDA?
Well it's about bleeping time. https://t.co/GiqfCVBWTX
— Scott Lincicome (@scottlincicome) October 5, 2021
Keep in mind, the company is already selling these tests in a number of countries including distribution through the NHS in the United Kingdom so it’s not some untested product:
Maker of newly-EUA’d rapid #covid19 test, ACON Laboratories, says its tests already have widespread distribution in the UK through the National Health Service pic.twitter.com/7ejeBKaM6E
— Meg Tirrell (@megtirrell) October 5, 2021
We *should* have had these tests months ago but, alas, instead with get a crippling FDA bureaucracy:
These could have been legal more than a year ago.
The leading cause of COVID deaths is the FDA. https://t.co/yzUc3gNvC1
— Libertarian Party NH (@LPNH) October 5, 2021
This headline is from almost a year ago:
Isn’t this utterly astounding…
That this headline is from almost a year ago!
We will still be asking the same question in Jan 2022 and we won’t have Trump to blame…https://t.co/neUd7YI9OW
— Michael Mina (@michaelmina_lab) October 5, 2021
Anyway, it’s good news yet long overdue:
Major FDA authorization: This will allow for significant expansion in availability of rapid, easy to use at home tests for Covid. Supply ready to go. These authorizations represent a major new policy effort by FDA to make tests for infectious disease accessible for consumer use. https://t.co/vdApj1D3G2
— Scott Gottlieb, MD (@ScottGottliebMD) October 5, 2021
***
Join the conversation as a VIP Member